Editas Medicine, Inc.(EDIT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

EDIT Editas Medicine, Inc.

交易中 12-24 12:10:04 EST

2.20

+0.01

+0.46%

最高2.24	最低2.17	成交量50.16万
今开2.17	昨收2.19	日振幅3.20%
总市值2.15亿	流通市值1.97亿	总股本9,762万
成交额110.73万	换手率0.56%	流通股本8,958万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"EDIT","market":"US","secType":"STK","nameCN":"Editas Medicine, Inc.","latestPrice":2.2,"timestamp":1766596204076,"preClose":2.19,"halted":0,"volume":501646,"delay":0,"floatShares":89583600,"shares":97618660,"eps":-2.349266,"marketStatus":"交易中","change":0.01,"latestTime":"12-24 12:10:04 EST","open":2.17,"high":2.24,"low":2.17,"amount":1107323.9494552,"amplitude":0.031963,"askPrice":2.2,"askSize":3400,"bidPrice":2.19,"bidSize":2700,"shortable":3,"etf":0,"ttmEps":-2.349266,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1766599200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":2.19,"preHourTrading":{"tag":"盘前","latestPrice":2.1804,"preClose":2.19,"latestTime":"09:06 EST","volume":8928,"amount":19375.584883199997,"timestamp":1766585171117},"postHourTrading":{"tag":"盘后","latestPrice":2.2,"preClose":2.19,"latestTime":"19:47 EST","volume":28909,"amount":63534.252,"timestamp":1766537240910},"volumeRatio":0.574602,"impliedVol":0.8731,"impliedVolPercentile":0.332},"requestUrl":"/m/hq/s/EDIT","defaultTab":"news","newsList":[{"id":"2584660378","title":"Editas Medicine, Inc.2025财年第三财季实现净利润-25.12百万美元，同比增加59.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584660378","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584660378?lang=zh_cn&edition=full","pubTime":"2025-11-17 00:00","pubTimestamp":1763308856,"startTime":"0","endTime":"0","summary":"11月17日，Editas Medicine, Inc.公布财报，公告显示公司2025财年第三财季净利润为-25.12百万美元，同比增加59.58%；其中营业收入为7.54百万美元，同比增加12260.66%，每股基本收益为-0.28美元。从资产负债表来看，Editas Medicine, Inc.总负债1.88亿美元，其中短期债务11.09百万美元，资产负债比为1.08，流动比率为0.03。机构评级：截至2025年11月17日，当前有10家机构对Editas Medicine, Inc.目标价做出预测，其中目标均价为4.91美元，其中最低目标价为1.00美元，最高目标价为13.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117000118950816e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117000118950816e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EDIT"],"gpt_icon":0},{"id":"1152882042","title":"Editas Medicine, Inc.：预计将在2026年中期提交Edit-401的IND/CTA，计划在2026年年底取得初步的人体概念验证数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1152882042","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152882042?lang=zh_cn&edition=full","pubTime":"2025-11-10 20:18","pubTimestamp":1762777090,"startTime":"0","endTime":"0","summary":"Editas Medicine, Inc.：预计将在2026年中期提交Edit-401的IND/CTA，计划在2026年年底取得初步的人体概念验证数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EDIT","BK4556","BK4139"],"gpt_icon":0},{"id":"2581832009","title":"Editas Medicine, Inc.盘中异动 早盘股价大跌7.99%报2.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581832009","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581832009?lang=zh_cn&edition=full","pubTime":"2025-11-07 22:30","pubTimestamp":1762525825,"startTime":"0","endTime":"0","summary":"北京时间2025年11月07日22时30分，Editas Medicine, Inc.股票出现异动，股价快速跳水7.99%。截至发稿，该股报2.48美元/股，成交量20.3179万股，换手率0.23%，振幅4.46%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107223025a490887e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107223025a490887e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","EDIT","BK4139"],"gpt_icon":0},{"id":"2577815478","title":"Editas Medicine, Inc.盘中异动 急速上涨6.10%报4.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2577815478","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577815478?lang=zh_cn&edition=full","pubTime":"2025-10-20 21:32","pubTimestamp":1760967179,"startTime":"0","endTime":"0","summary":"北京时间2025年10月20日21时32分，Editas Medicine, Inc.股票出现异动，股价快速拉升6.10%。截至发稿，该股报4.00美元/股，成交量4.4649万股，换手率0.05%，振幅3.98%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510202132599738ca4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510202132599738ca4f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","EDIT","BK4139"],"gpt_icon":0},{"id":"2576775466","title":"Editas Medicine, Inc.盘中异动 早盘急速拉升5.30%报4.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2576775466","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576775466?lang=zh_cn&edition=full","pubTime":"2025-10-16 21:36","pubTimestamp":1760621803,"startTime":"0","endTime":"0","summary":"北京时间2025年10月16日21时36分，Editas Medicine, Inc.股票出现异动，股价大幅拉升5.30%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510162136439731ec38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510162136439731ec38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","EDIT","BK4139"],"gpt_icon":0},{"id":"2575227701","title":"Editas Medicine, Inc.盘中异动 快速下跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575227701","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575227701?lang=zh_cn&edition=full","pubTime":"2025-10-14 21:31","pubTimestamp":1760448711,"startTime":"0","endTime":"0","summary":"北京时间2025年10月14日21时31分，Editas Medicine, Inc.股票出现波动，股价急速下挫5.06%。Editas Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.27%。其相关个股中，Pmgc Holdings Inc.、Astria Therapeutics, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Pmgc Holdings Inc.、Astria Therapeutics, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为1944.51%、17.68%、16.06%，振幅较大的相关个股有Pmgc Holdings Inc.、Osr Holdings, Inc.、Adaptimmune Therapeutics Plc，振幅分别为12.84%、8.05%、7.33%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251014213152972d982a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251014213152972d982a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EDIT","BK4139","BK4556"],"gpt_icon":0},{"id":"1134900386","title":"Editas Medicine在第32届欧洲基因与细胞治疗学会年会上公布Edit-401体内概念验证数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1134900386","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134900386?lang=zh_cn&edition=full","pubTime":"2025-10-09 23:02","pubTimestamp":1760022142,"startTime":"0","endTime":"0","summary":"Editas Medicine在第32届欧洲基因与细胞治疗学会(ESGCT)年会上发布了Edit-401的体内概念验证数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EDIT","BK4139","BK4556"],"gpt_icon":0},{"id":"2568234260","title":"Editas Medicine, Inc.盘中异动 早盘大幅拉升5.51%报2.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2568234260","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568234260?lang=zh_cn&edition=full","pubTime":"2025-09-18 21:31","pubTimestamp":1758202306,"startTime":"0","endTime":"0","summary":"北京时间2025年09月18日21时31分，Editas Medicine, Inc.股票出现异动，股价急速上涨5.51%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，89Bio, Inc.、Aptevo Therapeutics Inc.、Nanobiotix涨幅较大，Aptevo Therapeutics Inc.、Psyence Biomedical Ltd.、Biocardia, Inc.较为活跃，换手率分别为1787.19%、617.67%、244.86%，振幅较大的相关个股有Replimune Group, Inc.、Aptevo Therapeutics Inc.、Curanex Pharmaceuticals Inc，振幅分别为17.51%、16.31%、8.51%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250918213146a728723c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250918213146a728723c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BK4139","EDIT"],"gpt_icon":0},{"id":"2568484109","title":"Editas Medicine, Inc.盘中异动 早盘大幅下跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568484109","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568484109?lang=zh_cn&edition=full","pubTime":"2025-09-16 21:54","pubTimestamp":1758030886,"startTime":"0","endTime":"0","summary":"北京时间2025年09月16日21时54分，Editas Medicine, Inc.股票出现异动，股价大幅下挫5.06%。Editas Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.10%。其相关个股中，Surrozen Inc C/Wts 01/08/2031 、Aptevo Therapeutics Inc.、Adaptimmune Therapeutics Plc涨幅较大，Aptevo Therapeutics Inc.、Silo Pharma, Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为2221.24%、104.32%、80.41%，振幅较大的相关个股有Aptevo Therapeutics Inc.、Adaptimmune Therapeutics Plc、Ethzilla Corporation C/Wts 06/11/2025，振幅分别为40.97%、31.68%、23.68%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250916215447979642c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250916215447979642c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EDIT","BK4139","BK4556"],"gpt_icon":0},{"id":"2557457849","title":"Editas Medicine, Inc.盘中异动 股价大跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557457849","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557457849?lang=zh_cn&edition=full","pubTime":"2025-08-08 22:31","pubTimestamp":1754663482,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日22时31分，Editas Medicine, Inc.股票出现异动，股价快速跳水5.22%。Editas Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.75%。其相关个股中，Omniab Inc C/Wts 、Bioxcel Therapeutics, Inc.、Alector, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Biovie Inc.、Onconetix, Inc.较为活跃，换手率分别为407.89%、118.15%、94.79%，振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Cognition Therapeutics, Inc.，振幅分别为73.00%、30.00%、26.50%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808223122a47d72bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808223122a47d72bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BK4139","EDIT"],"gpt_icon":0},{"id":"2557530324","title":"Editas Medicine, Inc.盘中异动 急速下跌5.00%报2.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557530324","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557530324?lang=zh_cn&edition=full","pubTime":"2025-08-06 22:45","pubTimestamp":1754491521,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日22时45分，Editas Medicine, Inc.股票出现异动，股价急速下跌5.00%。Editas Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Biomx Inc.、Bioxcel Therapeutics, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Biomx Inc.、Psyence Biomedical Ltd.较为活跃，换手率分别为594.40%、349.90%、52.01%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Cingulate Inc C/Wts 10/12/2026 ，振幅分别为45.15%、44.74%、36.81%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080622452194d3994f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080622452194d3994f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BK4139","EDIT"],"gpt_icon":0},{"id":"2556380251","title":"Editas Medicine, Inc.盘中异动 早盘股价大涨5.16%报2.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556380251","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556380251?lang=zh_cn&edition=full","pubTime":"2025-08-04 22:32","pubTimestamp":1754317931,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日22时32分，Editas Medicine, Inc.股票出现异动，股价急速拉升5.16%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.78%。其相关个股中，Psyence Biomedical Ltd.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、凯信远达涨幅较大，Psyence Biomedical Ltd.、Soligenix, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为5096.53%、1307.76%、496.28%，振幅较大的相关个股有凯信远达、Psyence Biomedical Ltd.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为92.95%、77.54%、46.03%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080422321294cf03ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080422321294cf03ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EDIT","BK4139","BK4556"],"gpt_icon":0},{"id":"2556814388","title":"Editas Medicine, Inc.盘中异动 股价大跌5.18%报2.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556814388","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556814388?lang=zh_cn&edition=full","pubTime":"2025-08-01 22:02","pubTimestamp":1754056929,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日22时02分，Editas Medicine, Inc.股票出现异动，股价急速下挫5.18%。截至发稿，该股报2.38美元/股，成交量24.6861万股，换手率0.29%，振幅3.98%。Editas Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801220210972d0e10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801220210972d0e10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EDIT","BK4556"],"gpt_icon":0},{"id":"2555703421","title":"Editas Medicine, Inc.盘中异动 股价大跌5.08%报2.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555703421","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555703421?lang=zh_cn&edition=full","pubTime":"2025-07-29 00:48","pubTimestamp":1753721331,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日00时48分，Editas Medicine, Inc.股票出现波动，股价快速跳水5.08%。截至发稿，该股报2.99美元/股，成交量101.219万股，换手率1.21%，振幅6.03%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729004851a4681471&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729004851a4681471&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EDIT","BK4139","BK4556"],"gpt_icon":0},{"id":"2551121311","title":"Editas Medicine, Inc.盘中异动 急速上涨5.14%报2.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551121311","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551121311?lang=zh_cn&edition=full","pubTime":"2025-07-16 21:42","pubTimestamp":1752673336,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日21时42分，Editas Medicine, Inc.股票出现异动，股价快速上涨5.14%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.75%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507162142179544ed44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507162142179544ed44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EDIT","BK4556"],"gpt_icon":0},{"id":"2550954097","title":"Editas Medicine, Inc.盘中异动 早盘股价大跌5.23%报2.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550954097","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550954097?lang=zh_cn&edition=full","pubTime":"2025-07-11 22:36","pubTimestamp":1752244561,"startTime":"0","endTime":"0","summary":"北京时间2025年07月11日22时36分，Editas Medicine, Inc.股票出现波动，股价快速下跌5.23%。Editas Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.86%。其相关个股中，Mink Therapeutics, Inc.、Alterity Therapeutics Limited、Calcimedica, Inc.涨幅较大，Mink Therapeutics, Inc.、Cel-Sci Corporation、Dare Bioscience, Inc.较为活跃，换手率分别为441.21%、195.23%、81.82%，振幅较大的相关个股有Mink Therapeutics, Inc.、Cel-Sci Corporation、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 ，振幅分别为495.47%、74.61%、35.73%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711223602953ee544&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711223602953ee544&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","EDIT","BK4139"],"gpt_icon":0},{"id":"2549752387","title":"Editas Medicine, Inc.盘中异动 股价大涨6.30%报2.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549752387","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549752387?lang=zh_cn&edition=full","pubTime":"2025-07-08 21:36","pubTimestamp":1751981768,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日21时36分，Editas Medicine, Inc.股票出现波动，股价大幅拉升6.30%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Prokidney Corp.、Rallybio Corporation、Humacyte, Inc.涨幅较大，Zyversa Therapeutics, Inc.、Plus Therapeutics, Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为815.16%、130.03%、114.39%，振幅较大的相关个股有Prokidney Corp.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Sonnet Biotherapeutics Holdings, Inc.，振幅分别为37.91%、25.62%、19.03%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708213608979e6359&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708213608979e6359&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EDIT","BK4556","BK4139"],"gpt_icon":0},{"id":"2548189458","title":"Editas Medicine, Inc.盘中异动 快速拉升5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548189458","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548189458?lang=zh_cn&edition=full","pubTime":"2025-07-02 21:49","pubTimestamp":1751464163,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日21时49分，Editas Medicine, Inc.股票出现波动，股价快速上涨5.11%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.43%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702214923a72ac4df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702214923a72ac4df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BK4139","EDIT"],"gpt_icon":0},{"id":"2546731049","title":"Editas Medicine, Inc.盘中异动 早盘快速下挫5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546731049","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546731049?lang=zh_cn&edition=full","pubTime":"2025-06-26 22:12","pubTimestamp":1750947146,"startTime":"0","endTime":"0","summary":"北京时间2025年06月26日22时12分，Editas Medicine, Inc.股票出现异动，股价急速下挫5.02%。Editas Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.10%。其相关个股中，Vor Biopharma Inc.、Adial Pharmaceuticals, Inc、Vyne Therapeutics Inc.涨幅较大，Adial Pharmaceuticals, Inc、Plus Therapeutics, Inc.、Vor Biopharma Inc.较为活跃，换手率分别为974.92%、219.17%、90.12%，振幅较大的相关个股有Vor Biopharma Inc.、Apollomics Inc C/Wts 01/04/2028 、Vyne Therapeutics Inc.，振幅分别为91.63%、40.05%、28.10%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626221226a4bf5852&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626221226a4bf5852&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EDIT","BK4556","BK4139"],"gpt_icon":0},{"id":"2545445295","title":"Editas Medicine, Inc.盘中异动 临近午盘快速跳水5.18%报2.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545445295","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545445295?lang=zh_cn&edition=full","pubTime":"2025-06-24 00:00","pubTimestamp":1750694459,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日00时00分，Editas Medicine, Inc.股票出现异动，股价大幅下跌5.18%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Impact Biomedical, Inc.、Indaptus Therapeutics, Inc.、Cidara Therapeutics, Inc.涨幅较大，Impact Biomedical, Inc.、Indaptus Therapeutics, Inc.、Nucana Plc较为活跃，换手率分别为2592.25%、2039.94%、734.96%，振幅较大的相关个股有Impact Biomedical, Inc.、Indaptus Therapeutics, Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为273.41%、79.75%、71.02%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062400010095283b76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062400010095283b76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","EDIT","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.editasmedicine.com","stockEarnings":[{"period":"1week","weight":-0.1275},{"period":"1month","weight":-0.095},{"period":"3month","weight":-0.3501},{"period":"6month","weight":0.033},{"period":"1year","weight":0.752},{"period":"ytd","weight":0.7244}],"compareEarnings":[{"period":"1week","weight":0.0134},{"period":"1month","weight":0.0439},{"period":"3month","weight":0.0406},{"period":"6month","weight":0.1244},{"period":"1year","weight":0.1568},{"period":"ytd","weight":0.1738}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Editas Medicine, Inc.于2013年9月以Gengine, Inc.名字成立，后来在2013年11月更名为Editas Medicine, Inc.该公司是一家领先的基因研究公司，致力于通过纠正患者的致病基因治疗与基因相关的疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":-0.050907},{"month":2,"riseRate":0.444444,"avgChangeRate":0.072004},{"month":3,"riseRate":0.3,"avgChangeRate":-0.071533},{"month":4,"riseRate":0.4,"avgChangeRate":-0.024583},{"month":5,"riseRate":0.5,"avgChangeRate":0.001154},{"month":6,"riseRate":0.6,"avgChangeRate":0.089853},{"month":7,"riseRate":0.7,"avgChangeRate":0.035578},{"month":8,"riseRate":0.6,"avgChangeRate":0.036188},{"month":9,"riseRate":0.2,"avgChangeRate":-0.076361},{"month":10,"riseRate":0.4,"avgChangeRate":-0.058936},{"month":11,"riseRate":0.5,"avgChangeRate":0.071042},{"month":12,"riseRate":0.3,"avgChangeRate":0.028908}],"exchange":"NASDAQ","name":"Editas Medicine, Inc.","nameEN":"Editas Medicine"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Editas Medicine, Inc.(EDIT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Editas Medicine, Inc.(EDIT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Editas Medicine, Inc.,EDIT,Editas Medicine, Inc.股票,Editas Medicine, Inc.股票老虎,Editas Medicine, Inc.股票老虎国际,Editas Medicine, Inc.行情,Editas Medicine, Inc.股票行情,Editas Medicine, Inc.股价,Editas Medicine, Inc.股市,Editas Medicine, Inc.股票价格,Editas Medicine, Inc.股票交易,Editas Medicine, Inc.股票购买,Editas Medicine, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Editas Medicine, Inc.(EDIT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Editas Medicine, Inc.(EDIT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}